Literature DB >> 17340038

Assessing clinically meaningful end points for the management of actinic keratosis with diclofenac 3% gel.

Jason K Rivers, Jason J Rivers, John Wolf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17340038     DOI： 10.2340/00015555-0213

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  2 in total

1.  Use of Lesion Response Rate in Actinic Keratosis Trials.

Authors:  Rolf-Markus Szeimies; Petar Atanasov; Robert Bissonnette
Journal:  Dermatol Ther (Heidelb)       Date:  2016-09-19

2.  [Actinic keratosis: New concept and therapeutic update].

Authors:  Rafael Carmena-Ramón; Almudena Mateu-Puchades; Sergio Santos-Alarcón; Sofía Lucas-Truyols
Journal:  Aten Primaria       Date:  2017-04-17       Impact factor: 1.137
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.